Growth Metrics

Dr Reddys Laboratories (RDY) Long-Term Deferred Tax (2018 - 2025)

Historic Long-Term Deferred Tax for Dr Reddys Laboratories (RDY) over the last 13 years, with Q3 2025 value amounting to $260.4 million.

  • Dr Reddys Laboratories' Long-Term Deferred Tax rose 2479.85% to $260.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $260.4 million, marking a year-over-year increase of 2479.85%. This contributed to the annual value of $217.0 million for FY2025, which is 6821.71% up from last year.
  • According to the latest figures from Q3 2025, Dr Reddys Laboratories' Long-Term Deferred Tax is $260.4 million, which was up 2479.85% from $213.7 million recorded in Q1 2025.
  • In the past 5 years, Dr Reddys Laboratories' Long-Term Deferred Tax registered a high of $260.4 million during Q3 2025, and its lowest value of $87.5 million during Q1 2023.
  • Moreover, its 5-year median value for Long-Term Deferred Tax was $130.4 million (2023), whereas its average is $150.8 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Long-Term Deferred Tax crashed by 2544.04% in 2022, and later skyrocketed by 6474.35% in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Long-Term Deferred Tax (Quarter) stood at $127.2 million in 2021, then decreased by 25.44% to $94.8 million in 2022, then surged by 38.24% to $131.1 million in 2023, then soared by 59.18% to $208.6 million in 2024, then rose by 24.8% to $260.4 million in 2025.
  • Its Long-Term Deferred Tax stands at $260.4 million for Q3 2025, versus $213.7 million for Q1 2025 and $208.6 million for Q3 2024.